Epstein–Barr virus-associated diseases are important global health concerns. As a group I
carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial-and …

Nasopharyngeal carcinoma (NPC) results from the aberrant and uncontrolled growth of the
nasopharyngeal epithelium. It is highly associated with the Epstein–Barr virus, especially in …

Background The relationship between circulating exosomal circular RNA (circRNA) and
prognosis of patients with nasopharyngeal carcinoma (NPC) remain unknown. This study …

Background Induction chemotherapy plus concurrent chemoradiotherapy (IC+ CCRT) is a
standard treatment regimen for locally advanced nasopharyngeal carcinoma (LA-NPC) …

Background Nasopharyngeal carcinoma is a multifactorial disease mainly affecting the
Asian and North African populations including Morocco. This study aimed to determine the …

Nasopharyngeal carcinoma (NPC) is a distinct malignancy from other epithelial head and
neck cancers. The endemic variant is invariably associated with the Epstein-Barr virus …

Objective: To explore a way to reverse the drug resistance for irradiated CNE-1 human
nasopharyngeal carcinoma cells and try to develop a new high efficacy with low toxicity …

Identifying key genes and small molecule compounds for nasop... : Medicine Identifying key
genes and small molecule compounds for nasopharyngeal carcinoma by various …

Purpose We compared, in this pooled analysis, the differences in efficacy and safety
between three induction chemotherapy regimens including gemcitabine plus cisplatin (GP) …

Nasopharyngeal carcinoma is an endemic disease with a high prevalence in Southeast
Asia, Mediterranean countries, and Northern Africa. With substantial advances in screening …